{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed with First-Line Osimertinib Treatment and whose Tumors harbor a C797S mutation within the Epidermal Growth Factor Receptor Gene","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-ii-open-label-multicenter-single-arm-study-of-wsd0922-fu-for-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-whose-disease-has-progressed-with-first-line-osimertinib-2\/#breadcrumbitem"}]}